Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Comparative study of brain aging in healthy individuals and those with multiple sclerosis

Official title: Brain Aging - a Comparative Study in Healthy and Patients With Multiple Sclerosis as Model of a Chronic Neuroinflammatory Disorder (BrainAgeMS)

Run by Insel Gruppe AG, University Hospital Bern · NCT06221631 · Data updated 2026-11-12

This study is testing new MRI techniques to see how brain aging differs between healthy people and those with multiple sclerosis.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern, Canton of Bern)
StatusRecruiting
StartedAugust 27, 2024
Main results expectedMarch 2028
Study endsOctober 2028
Registry record updatedFebruary 13, 2026
Trial IDNCT06221631 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include healthy individuals and patients diagnosed with multiple sclerosis aged 18 to 65 with an EDSS score of 6.0 or lower.

Probably not a fit

Patients with other neurological diseases or those who do not meet the inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates new quantitative MRI sequences to assess age-specific data for predicting brain aging in both healthy individuals and patients with multiple sclerosis. Participants will undergo blood examinations to determine biological age, clinical evaluations for various parameters, and advanced MRI scans using chemical exchange saturation transfer and T1-relaxometry on a 7 Tesla MRI. The data collected from healthy controls will help establish a normative brain age dataset, which could be utilized for training predictive models for brain aging.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of brain aging in multiple sclerosis and improve predictive models for patient outcomes.

How similar studies have gone: While studies on brain aging and multiple sclerosis exist, this approach utilizing advanced MRI techniques and biological age assessment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Informed Consent signed by the subject

* Group 1: Any healthy individual between 18 and 65 years of age
* Group 2: Any individuals with any diagnosis of Multiple Sclerosis between 18 and 65 years of age and EDSS ≤6.0.

Exclusion Criteria:

* Group 1 and 2: Any other neurological disease except primary headaches: insufficient language skills in German or French; pregnancy, lactation, any contraindication for MRI (active implants, passive ferromagnetic implants, passive non-ferromagnetic metallic implants \>4cm in the region covered by the active RF coils, large tattoos inside a region covered by the active radiofrequency (RF) coils, claustrophobia or suspected/known non-compliance), smoking within the last 10 years prior recruitment, any other drug consumption except moderate alcohol intake (less than a standard drink containing 10 grams of alcohol per day) or use of medical cannabis, any previous head trauma (with known/suspected intracranial consequences), Body Mass Index (BMI) \>30, and any other chronic progressive disease.

  * Specific Criteria for group 1: The calculated biological age (BioAge R Package algorithm) differs by \> -8/+1 years from the chronological age. These patients will not be further invited for a study visit with clinical examination and MRI.
  * Specific Criteria for group 2: EDSS \> 6.0 as this impacts physical testing; clinical relapse within the last 6 months

Where it's running

  • Inselspital Bern
    Bern, Canton of Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.